Examkin

Soru

Zorluk: OrtaHematology and Oncology

A 45-year-old man presents to the emergency department with epistaxis, bleeding gums, and easy bruising for the past three days. A complete blood count reveals a hemoglobin of 8.2 g/dL8.2 \text{ g/dL}, a leukocyte count of 28,000/μL28,000/\mu L, and a platelet count of 18,000/μL18,000/\mu L. Coagulation studies demonstrate a prolonged prothrombin time (PT), prolonged activated partial thromboplastin time (aPTT), profoundly low fibrinogen, and elevated D-dimer. A peripheral blood smear shows atypical cells with abundant cytoplasm, heavy azurophilic granulation, and bundles of Auer rods.

Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for this patient.

  1. 1Administer all-trans retinoic acid (ATRA) immediately based on clinical and morphologic suspicion.
  2. 2Perform a bone marrow aspiration and send for cytogenetic analysis to identify the t(15;17)t(15;17) translocation.
  3. 3Initiate targeted induction therapy with arsenic trioxide.
  4. 4Administer high-dose dexamethasone if the patient develops unexplained fever and pulmonary infiltrates.

Cevap

The correct sequence is to first immediately administer all-trans retinoic acid (ATRA) upon clinical suspicion, then perform a bone marrow biopsy for definitive genetic confirmation, followed by the initiation of a full induction regimen (e.g., arsenic trioxide), and finally, monitoring for and treating differentiation syndrome with dexamethasone if it arises.
The proper sequence for managing acute promyelocytic leukemia prioritizes immediate survival. ATRA must be given on clinical suspicion to halt the DIC process. Once the bleeding risk is mitigated, bone marrow sampling provides the definitive diagnosis (PML-RARA). With the diagnosis confirmed, a full course of targeted induction is delivered, followed by vigilance for therapy-induced complications like differentiation syndrome.

Adım Adım Çözüm

1
Recognize the clinical presentation of Acute Promyelocytic Leukemia (APL).
The patient's smear showing bundles of Auer rods and lab profile indicating disseminated intravascular coagulation (DIC) are highly suggestive of APL.
Identifying APL early is critical because it is a medical emergency requiring distinct initial management to prevent fatal hemorrhage.
2
Determine the immediate next step in management.
Administer ATRA without delay.
ATRA promotes the differentiation of the malignant promyelocytes, rapidly reversing the life-threatening coagulopathy. It must not be delayed for bone marrow biopsy results.
3
Determine the subsequent diagnostic and definitive management steps.
Perform bone marrow biopsy, then start full induction therapy.
Cytogenetic confirmation of the t(15;17)t(15;17) translocation (PML-RARA) is required for a definitive diagnosis, after which a complete induction protocol (like ATRA plus arsenic trioxide) is executed.
4
Anticipate treatment complications.
Monitor for differentiation syndrome and treat with dexamethasone.
As leukemic cells differentiate, they can release cytokines and infiltrate tissues, causing pulmonary infiltrates, fever, and hypoxia, necessitating prompt steroid therapy.

Anahtar Kavram

Sequential diagnosis and management of Acute Promyelocytic Leukemia (APL)
Bu soruyu puanla

Konular

Hematology and Oncology

Bu konudan daha fazla soru